Efficacy and toxicity of the FLAG/Daunoxome® association in children with relapsed or resistant acute myeloid leukemia (AML).

被引：0
|
作者：
Rizzari, C
Micalizzi, C
Locatelli, F
Maffeis, B
Daldossi, S
Ladogana, S
Casale, F
Fagioli, F
Lippi, A
Colombini, A
Pession, A
机构：
[1] Univ Milano Bicocca, Osped S Gerardo, Monza, Italy
[2] IRCCS G Gaslini, Genoa, Italy
[3] IRCCS Policlin S Matteo, Pavia, Italy
[4] Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[5] Univ Naples Federico II, Naples, Italy
[6] Osped Infantile Regina Margherita, Turin, Italy
[7] Azienda Osped Meyer, Florence, Italy
[8] Univ Bologna, I-40126 Bologna, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1334
引用
下载
收藏
页码：344A / 344A
页数：1
相关论文
共 50 条
  • [11] Mito-FLAG as salvage therapy for relapsed and refractory acute myeloid leukemia
    Hänel, M
    Friedrichsen, K
    Hänel, A
    Herbst, R
    Morgner, A
    Neser, S
    Nicklisch, M
    Teich, M
    Ehninger, G
    Fiedler, F
    ONKOLOGIE, 2001, 24 (04): : 356 - 360
  • [12] FLAG with Oral Fludarabine for Primary Refractory or Relapsed Acute Lymphoid or Myeloid Leukemia
    Demichelis, Roberta
    Crespo, Erick
    Perez, Fernando
    Valencia, Ubaldo
    Guzman, Patricia
    BLOOD, 2014, 124 (21)
  • [13] Venetoclax Combined With FLAG-IDA in Refractory or Relapsed Acute Myeloid Leukemia
    Wille, Kai
    Dumke, Marvin
    Wilsdorf, Nadine
    Sadjadian, Parvis
    Schneider, Artur
    Jender-Bartling, Stephanie
    Kolatzki, Vera
    Horstmann, Anette
    Meixner, Raphael
    Jimenez-Munoz, Marina
    Fuchs, Christiane
    Tischler, Hans-Joachim
    Griesshammer, Martin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024,
  • [14] Low efficacy of methotrexate in childhood acute myeloid leukemia (AML): Single-agent therapeutic window study in relapsed AML
    Kaspers, G. J. L.
    Reinhardt, D.
    Fleischhack, G.
    Armendariz, H.
    Stark, B.
    Zwaan, C. M.
    Zimmermann, M.
    Creutzig, U.
    PEDIATRIC BLOOD & CANCER, 2006, 47 (05) : 539 - 542
  • [15] FLAG-IDA as frontline induction or salvage therapy for patients with high risk and/or relapsed or refractory acute myeloid leukemia (AML)
    Bhella, Sita
    Atenafu, Eshetu G.
    Schuh, Andre C.
    Minden, Mark D.
    Schimmer, Aaron David
    Gupta, Vikas
    Seftel, Matthew D.
    Alam, Naheed
    Lutynski, Andrzej
    Rydlewski, Anna
    Rostom, Amr
    Yee, Karen W. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [16] Combinations of topotecan and liposomal daunorubicin (Daunoxome) in refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Giles, FJ
    Kantarjian, HM
    Cortes, JE
    Koller, C
    Thomas, D
    O'Brien, SM
    Estey, E
    Beran, M
    BLOOD, 1999, 94 (10) : 230B - 230B
  • [17] EFFECT OF FLAG REGIMEN IN TREATMENT OF CHILDREN WITH ACUTE REFRACTORY AND RELAPSED LEUKEMIA
    Lin, Y.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 213 - 213
  • [18] Efficacy of Single-Agent Decitabine in Relapsed and Primary Refractory (rel/ref) Acute Myeloid Leukemia (AML)
    Hantel, Andrew
    Khan, Niloufer
    Larson, Richard A.
    Godley, Lucy A.
    Thirman, Michael J.
    Artz, Andrew
    Odenike, Olatoyosi
    Liu, Hongtao
    Churpek, Jane E.
    King, Darren
    Rich, Elizabeth
    Choi, Kwang Jin
    Knoebel, Randall W.
    Stock, Wendy
    BLOOD, 2015, 126 (23)
  • [19] CLOFARABINE TOXICITY IN RELAPSED OR REFRACTORY ACUTE LEUKEMIA IN CHILDREN
    Kocak, U.
    Oner, N.
    Isik, M.
    Sal, A. E.
    Tekkesin, F.
    Altan, I.
    Kaya, Z.
    Yenicesu, I.
    Gursel, T.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S253 - S253
  • [20] Pembrolizumab and decitabine for relapsed and refractory acute myeloid leukemia (PD-AML)
    Lai, Catherine
    Karolyn, Oetjen
    Lindblad, Katherine
    Destefano, Christin
    Goswami, Meghali
    Wong, Hong Yuen
    Intrater, Therese
    Draper, Debbie
    Dillon, Laura
    Hourigan, Christopher
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345